Loading...
Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: We conducted a meta-analysis to evaluate the efficacy and safety of upfront add-on immunotherapy for advanced non-small cell lung cancers (NSCLC). METHODS: We performed a literature search on first-line chemotherapy ± immunotherapy in NSCLC. We utilized Revman version 5.3 to calculate th...
Na minha lista:
| Udgivet i: | Future Sci OA |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Science Ltd
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787520/ https://ncbi.nlm.nih.gov/pubmed/31608159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2019-0081 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|